|
LZTFL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88657986402541E-15 |
| Normal-vs-Stage2 |
1.8826000003358E-07 |
| Normal-vs-Stage3 |
3.77475828372553E-15 |
| Normal-vs-Stage4 |
1.52100554373646E-14 |
| Stage1-vs-Stage2 |
4.154400E-01 |
| Stage1-vs-Stage3 |
9.446100E-02 |
| Stage1-vs-Stage4 |
3.999800E-03 |
| Stage2-vs-Stage3 |
5.858000E-02 |
| Stage2-vs-Stage4 |
7.283600E-03 |
| Stage3-vs-Stage4 |
2.512200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.178740E-04 |
| Normal-vs-Asian |
7.60810303646053E-11 |
| Caucasian-vs-AfricanAmerican |
1.383180E-01 |
| Caucasian-vs-Asian |
7.751000E-01 |
| AfricanAmerican-vs-Asian |
3.015600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27675647831893E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.027600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68254299381942E-12 |
| Normal-vs-Age(41-60Yrs) |
1.56541446472147E-14 |
| Normal-vs-Age(61-80Yrs) |
1.64601665630926E-12 |
| Normal-vs-Age(81-100Yrs) |
1.279740E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.587200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.483600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.741800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.275800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.534800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.994800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.373300E-04 |
| Classical-VS-Follicular |
1.008410E-01 |
| Classical-VS-Other |
6.639400E-01 |
| Classical-VS-Normal |
3.16100479125225E-11 |
| Tall-VS-Follicular |
5.78439999999736E-05 |
| Tall-VS-Other |
4.420400E-01 |
| Tall-VS-Normal |
1.01030295240889E-14 |
| Follicular-VS-Other |
3.948000E-01 |
| Follicular-VS-Normal |
2.07399999951896E-07 |
| Other-VS-Normal |
1.562050E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.22675261247241E-14 |
| Normal-vs-N1 |
7.32747196252603E-15 |
| N0-vs-N1 |
2.122000E-03 |
|
|
